The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
OBN Launch BioForward® Conference - a unique, high-quality, international conference, focussed on creating and developing a practical roadmap for early stage, emerging, and developing companies to achieve sustainable business success and growth.
Read the rest of entry »
Company to be first occupier of the Park’s state-of-the-art Schrödinger Building
Arcinova was launched in February 2016, following the acquisition of the Covance site in Alnwick, by Arc Trinova Limited, a new company formed by Ian Shott and Paul Ryan, owners of Shott Trinova LLP.
OxSyBio, an Oxford University biotech spinout company developing 3D printer technology capable of printing biological materials with a diverse range of therapeutic purposes, has secured £10m in Series A financing from Woodford Investment Management alongside new and existing backers.
Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens, is pleased to announce that is has been awarded a new grant by Innovate UK, the UK’s innovation agency. The grant, awarded as part of Innovate UK’s Precision Medicine competition, will support the project “Prostate Cancer Chemotherapy Precision Dosing”.
Acquisition establishes an Asia Pacific Headquarters for PCI
Congenica, a global provider of clinical genomics interpretation software, announced today that it has received certification in ISO 13485:2016, a quality management system for medical devices that supports comprehensive policies and processes across the entire business.
On the 19th of February, Mologic were visited by Minister of State and NE Beds MP @AlistairBurtUK to hear all about their malaria diagnostics research. He was especially interested from the perspective of the Department for International Development.
Prokarium, the UK-based synthetic biology company that has developed Vaxonella, an oral, thermostable vaccine delivery platform, today announced the completion of a $10 million investment round.
Mologic is proud to announce a partnership with Fraunhofer on point-of-care diagnosis and antibiotic susceptibility test for Urinary Tract Infections.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, firstname.lastname@example.org, and we will post.